tradingkey.logo

Champions Oncology Inc

CSBR
6.760USD
-0.040-0.59%
Cierre 11/04, 16:00ETCotizaciones retrasadas 15 min
93.21MCap. mercado
31.58P/E TTM

Champions Oncology Inc

6.760
-0.040-0.59%

Más Datos de Champions Oncology Inc Compañía

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Información de Champions Oncology Inc

Símbolo de cotizaciónCSBR
Nombre de la empresaChampions Oncology Inc
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoMr. Robert (Rob) Brainin
Número de empleados213
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 30
DirecciónOne University Plaza,
CiudadHACKENSACK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal07601
Teléfono12018088400
Sitio Webhttps://championsoncology.com
Símbolo de cotizaciónCSBR
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoMr. Robert (Rob) Brainin

Ejecutivos de Champions Oncology Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
962.13K
--
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+77.99%
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
962.13K
--
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+77.99%
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--

Desglose de ingresos

FY2026Q1
FY2025
FY2025Q3
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
13.99M
0.00%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Battery Management Corp
17.39%
New Enterprise Associates (NEA)
12.43%
Ackerman (Joel)
6.98%
West Elk Capital, LLC
6.40%
Morris (Ronnie)
6.23%
Otro
50.57%
Accionistas
Accionistas
Proporción
Battery Management Corp
17.39%
New Enterprise Associates (NEA)
12.43%
Ackerman (Joel)
6.98%
West Elk Capital, LLC
6.40%
Morris (Ronnie)
6.23%
Otro
50.57%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
26.18%
Investment Advisor
22.65%
Venture Capital
12.53%
Hedge Fund
7.96%
Investment Advisor/Hedge Fund
4.68%
Research Firm
0.37%
Otro
25.63%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
61
6.64M
48.18%
-636.69K
2025Q2
69
10.40M
75.49%
-178.12K
2025Q1
71
10.39M
75.16%
-168.96K
2024Q4
61
10.19M
73.72%
-652.40K
2024Q3
60
10.19M
74.57%
-703.73K
2024Q2
64
9.36M
69.10%
-280.60K
2024Q1
64
9.22M
68.06%
-286.03K
2023Q4
62
9.19M
67.80%
-359.18K
2023Q3
68
10.27M
76.17%
-73.57K
2023Q2
73
10.30M
76.08%
-426.58K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Battery Management Corp
2.40M
17.39%
-23.97K
-0.99%
Aug 22, 2025
New Enterprise Associates (NEA)
1.71M
12.43%
--
--
Jun 30, 2025
Ackerman (Joel)
962.13K
6.98%
--
--
Aug 22, 2025
West Elk Capital, LLC
882.58K
6.4%
-210.81K
-19.28%
Sep 30, 2024
Morris (Ronnie)
858.88K
6.23%
--
--
Aug 22, 2025
Sidransky (David)
767.04K
5.56%
--
--
Aug 22, 2025
Pessin (Norman H)
742.16K
5.38%
--
--
Aug 22, 2025
Tocqueville Asset Management LP
399.88K
2.9%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
327.03K
2.37%
+19.16K
+6.22%
Jun 30, 2025
Mendelson (Daniel Newman)
198.63K
1.44%
--
--
Aug 22, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proporción0.01%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI